J&J Launches AI in Surgery Funding via Polyphonic™ Fund
J&J invests $100M in AI in surgery funding to drive smarter surgical solutions.
Read MorePosted by Shajini | Jun 27, 2025 | News, Orthopaedics
J&J invests $100M in AI in surgery funding to drive smarter surgical solutions.
Read MorePosted by Shajini | Jun 27, 2025 | FDA Updates, News, Orthopaedics |
Stryker FDA-cleared InCompass Ankle; protein degrader partnerships drive innovation.
Read MorePosted by Shajini | Jun 27, 2025 | Litigation, Law & Policy, Neurology, News, Pricing & Market Access
Medicare exoskeleton coverage approved for ReWalk Personal Exoskeleton, sets key precedent.
Read MorePosted by Shajini | Jun 27, 2025 | Dealstreet, Neurology, News |
Vor Bio, RemeGen sign Global License Agreement for RC98 development.
Read MorePosted by Shajini | Jun 27, 2025 | Cardiometabolic, Dealstreet, News
Novartis makes a $750M flagship pact to address cardiovascular disease innovation.
Read More